pamidronate has been researched along with Acute Kidney Injury in 11 studies
Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary objective was to compare the incidence of acute kidney injury (AKI) within 7 days of receiving pamidronate for the treatment of HCM with pre-existing renal dysfunction versus normal renal function at the time of pamidronate administration." | 8.02 | Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction. ( Norman, SJ; Reeves, DJ; Saum, LM, 2021) |
| " Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome." | 7.88 | Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome. ( Baş, VN; Baştuğ, F; Çetinkaya, H; Nalçacıoğlu, H; Tekatlı-Çelik, B; Yel, S, 2018) |
| "Pamidronate can rarely cause (collapsing) focal segmental glomerular sclerosis with the nephrotic syndrome and renal insufficiency." | 4.88 | Renal complications from bisphosphonate treatment. ( Hirschberg, R, 2012) |
| "The primary objective was to compare the incidence of acute kidney injury (AKI) within 7 days of receiving pamidronate for the treatment of HCM with pre-existing renal dysfunction versus normal renal function at the time of pamidronate administration." | 4.02 | Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction. ( Norman, SJ; Reeves, DJ; Saum, LM, 2021) |
| " Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome." | 3.88 | Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome. ( Baş, VN; Baştuğ, F; Çetinkaya, H; Nalçacıoğlu, H; Tekatlı-Çelik, B; Yel, S, 2018) |
| "Hypocalcemia was treated with calcium and vitamin D3 supplements." | 2.44 | [Zoledronate-associated end stage renal failure and hypocalcaemia]. ( Bodmer, M; Kummer, O; Ramazzina, C; Rätz Bravo, AE; Zysset Aschmann, Y, 2007) |
| "The hypercalcemia was refractory to extensive hydration and calcitonin, but was ameliorated by pamidronate." | 1.30 | Hypercalcemia in an euthyroid patient with secondary hypoadrenalism and diabetes insipidus due to hypothalamic tumor. ( Demura, H; Hotta, M; Sato, K; Shibasaki, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Norman, SJ | 1 |
| Reeves, DJ | 1 |
| Saum, LM | 1 |
| Satyarengga, M | 1 |
| Silver, KD | 1 |
| Baştuğ, F | 1 |
| Nalçacıoğlu, H | 1 |
| Baş, VN | 1 |
| Tekatlı-Çelik, B | 1 |
| Çetinkaya, H | 1 |
| Yel, S | 1 |
| Perazella, MA | 1 |
| Moeckel, GW | 1 |
| Hirschberg, R | 1 |
| Henley, D | 1 |
| Kaye, J | 1 |
| Walsh, J | 1 |
| Cull, G | 1 |
| Nasr, SH | 1 |
| Preddie, DC | 1 |
| Markowitz, GS | 1 |
| Appel, GB | 1 |
| D'Agati, VD | 1 |
| Ramazzina, C | 1 |
| Zysset Aschmann, Y | 1 |
| Kummer, O | 1 |
| Rätz Bravo, AE | 1 |
| Bodmer, M | 1 |
| Tamion, F | 1 |
| Bonmarchand, F | 1 |
| Girault, C | 1 |
| Chevron, V | 1 |
| Leroy, J | 1 |
| Hotta, M | 1 |
| Sato, K | 1 |
| Shibasaki, T | 1 |
| Demura, H | 1 |
| Yap, AS | 1 |
| Hockings, GI | 1 |
| Fleming, SJ | 1 |
| Khafagi, FA | 1 |
3 reviews available for pamidronate and Acute Kidney Injury
| Article | Year |
|---|---|
Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.
Topics: Acute Kidney Injury; Antineoplastic Agents; Cisplatin; Diphosphonates; Humans; Ifosfamide; Kidney Gl | 2010 |
Renal complications from bisphosphonate treatment.
Topics: Acute Kidney Injury; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Kidney; Kidney Diseases; Ne | 2012 |
[Zoledronate-associated end stage renal failure and hypocalcaemia].
Topics: Acute Kidney Injury; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; | 2007 |
8 other studies available for pamidronate and Acute Kidney Injury
| Article | Year |
|---|---|
Use of Pamidronate for Hypercalcemia of Malignancy in Renal Dysfunction.
Topics: Acute Kidney Injury; Diphosphonates; Humans; Hypercalcemia; Indiana; Neoplasms; Pamidronate; Retrosp | 2021 |
Severe hypercalcaemia due to household cleaner ingestion.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Bone Density Conservation Agents; Eating; Household P | 2019 |
Acute renal failure due to severe hypercalcemia and nephrocalcinosis treated with two doses of pamidronate in an infant with Williams-Beuren syndrome.
Topics: Acute Kidney Injury; Bone Density Conservation Agents; Female; Humans; Hypercalcemia; In Situ Hybrid | 2018 |
Symptomatic hypocalcaemia and renal impairment associated with bisphosphonate treatment in patients with multiple myeloma.
Topics: Acute Kidney Injury; Aged; Bone Density Conservation Agents; Calcitriol; Calcium Carbonate; Diphosph | 2005 |
Multiple myeloma, nephrotic syndrome and crystalloid inclusions in podocytes.
Topics: Acute Kidney Injury; Albumins; Bone Density Conservation Agents; Bone Diseases, Metabolic; Creatinin | 2006 |
Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia.
Topics: Acute Kidney Injury; Adult; Diphosphonates; Female; Humans; Hypercalcemia; Immobilization; Injection | 1995 |
Hypercalcemia in an euthyroid patient with secondary hypoadrenalism and diabetes insipidus due to hypothalamic tumor.
Topics: Acute Kidney Injury; Adrenal Insufficiency; Adult; Antineoplastic Agents; Diabetes Insipidus; Diphos | 1998 |
Use of aminohydroxypropylidene bisphosphonate (AHPrBP, "APD") for the treatment of hypercalcemia in patients with renal impairment.
Topics: Acute Kidney Injury; Adult; Diphosphonates; Female; Humans; Hypercalcemia; Kidney Failure, Chronic; | 1990 |